So, the natural question for Revolution Medicines (NASDAQ:RVMD) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual ...

Good day, and thank you for standing by. Welcome to the Revolution Medicines Q1 2025 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

So, the natural question for Revolution Medicines (NASDAQ:RVMD) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual (negative) ...

Revolution Medicines, Inc.’s RVMD share price has surged by 5.47%, which has investors questioning if this is right time to ...

Revolution Medicines reiterated its 2025 financial guidance, projecting a full-year GAAP net loss between $840 million and $900 million, inclusive of $115 million to $130 million in stock-based ...

Good day, and thank you for standing by. Welcome to the Revolution Medicines Q1 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.

Revolution Medicines Inc. (RVMD) experienced a notable stock price increase following its Q1 2025 earnings call, with shares rising by 8.9% in aftermarket trading to $41.01. According to ...

REDWOOD CITY, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...

May 07, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today ...

Needham & Company LLC restated their buy rating on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a research note released on Thursday,Benzinga reports. The firm currently has a $ ...